← All stocks

Forte Biosciences, Inc.

FBRX Net selling
CIK 0001419041 #2191 in the set updated 19 Sep 2026
Bought (120 mo)
$2.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.45M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$4.45M
3 of 3 sales
Net
−$1.83M
−$1.83M against sales at will

By person

16 insiders · 35 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Wagner Paul A.
SEE REMARKS
$281.07K (14)
$4.35M (1)
−$4.07M
0
$0.00
−100.0%
Hasnain Faheem
Director
$1.20M (4)
+$1.20M
245,857
$6.47M
Riley Antony A
CHIEF FINANCIAL OFFICER
$476.28K (4)
$106.11K (2)
+$370.17K
0
$0.00
GRUBER HARRY E
President, Science&Innovation
$272.78K (2)
+$272.78K
441,438
$11.62M
+11.8%
Oliveira Steven Michael
10% owner
$176.17K (2)
+$176.17K
4,139,450
$108.97M
+3.5%
SCHIMMEL PAUL
Director
$100.00K (1)
+$100.00K
44,827
$1.18M
FOLETTA MARK G
EVP & Chief Financial Officer
$71.48K (2)
+$71.48K
15,042
$395.99K
+491.7%
Das Asha
SVP & Chief Medical Officer
$25.00K (1)
+$25.00K
5,000
$131.63K
Duvall Martin J
Chief Executive Officer
$21.68K (1)
+$21.68K
13,605
$358.16K
+436.9%
Jolly Douglas
EVP, Research & Pharm Devel
436,956
$11.50M
+0.5%
Chen Hubert C
See remarks
93,405
$2.46M
Williams Donald Allen
Director
59,405
$1.56M
DARCY THOMAS E
Director
26,995
$710.66K
+9.6%
BERGER FRANKLIN M
Director
25,335
$666.96K
GRYSKA DAVID W
Director
0
$0.00
Kornfeld Steven
Director
0
$0.00

No percentages here. This company's share count has moved by a factor of 14.5 over the window, from 1,461,934 to 21,229,087 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Riley Antony A
30 Dec 2025
CHIEF FINANCIAL OFFICER
Buy
9,680
$26.33
$254.83K
Riley Antony A
21 Nov 2024
CHIEF FINANCIAL OFFICER
Buy
22,514
$5.55
$125.00K
Wagner Paul A.
18 Dec 2023
See Remarks
Buy
10,000
$0.75
$7.53K
Wagner Paul A.
14 Dec 2023
See Remarks
Buy
10,000
$0.72
$7.20K
Wagner Paul A.
13 Dec 2023
See Remarks
Buy
10,520
$0.70
$7.35K
Wagner Paul A.
12 Dec 2023
See Remarks
Buy
4,776
$0.65
$3.09K
Wagner Paul A.
11 Dec 2023
See Remarks
Buy
25,000
$0.65
$16.19K
Wagner Paul A.
8 Dec 2023
See Remarks
Buy
15,000
$0.62
$9.30K
Wagner Paul A.
7 Dec 2023
See Remarks
Buy
36,203
$0.58
$21.17K
Wagner Paul A.
22 Nov 2023
See Remarks
Buy
400
$0.43
$172.00
Wagner Paul A.
20 Nov 2023
See Remarks
Buy
100
$0.43
$42.51
Wagner Paul A.
20 Nov 2023
See Remarks
Buy
1,566
$0.43
$673.38
Wagner Paul A.
20 Nov 2023
See Remarks
Buy
5,300
$0.44
$2.33K
Wagner Paul A.
16 Dec 2022
See Remarks
Buy
44,024
$1.07
$47.00K
Wagner Paul A.
15 Dec 2022
See Remarks
Buy
55,976
$1.03
$57.67K
Riley Antony A
7 Sep 2021
Chief Financial Officer
Sell
3,516
$4.27
$15.01K
Riley Antony A
7 Sep 2021
Chief Financial Officer
Sell
21,484
$4.24
$91.09K
Wagner Paul A.
7 Sep 2021
See Remarks
Sell
1,000,000
$4.35
$4.35M
DARCY THOMAS E
13 Jan 2021
Director
Exercised, kept
500
$9.59
$4.79K
Riley Antony A
29 Jun 2020
Chief Financial Officer
Buy
2,000
$14.11
$28.22K
Riley Antony A
26 Jun 2020
Chief Financial Officer
Buy
4,700
$14.52
$68.23K
Wagner Paul A.
25 Jun 2020
See Remarks
Buy
7,000
$14.48
$101.36K
Oliveira Steven Michael
14 Apr 2020
10% owner
Buy indirect
74,301
$1.19
$88.42K
Oliveira Steven Michael
2 Mar 2020
10% owner
Buy indirect
65,149
$1.35
$87.76K
Hasnain Faheem
30 May 2019
Director
Buy indirect
250
$5.15
$1.29K
Hasnain Faheem
30 May 2019
Director
Buy indirect
3,890
$5.30
$20.61K
Hasnain Faheem
30 May 2019
Director
Buy indirect
38,860
$4.59
$178.41K
Duvall Martin J
28 May 2019
Chief Executive Officer
Buy
5,000
$4.34
$21.68K
FOLETTA MARK G
28 May 2019
EVP & Chief Financial Officer
Buy
5,000
$4.30
$21.48K
GRUBER HARRY E
24 May 2019
President, Science&Innovation
Buy
5,000
$4.56
$22.78K
Hasnain Faheem
19 Apr 2017
Director
Buy indirect
100,000
$10.00
$1.00M
SCHIMMEL PAUL
19 Apr 2017
Director
Buy indirect
10,000
$10.00
$100.00K
GRUBER HARRY E
19 Apr 2017
President, Research & Devel
Buy indirect
25,000
$10.00
$250.00K
FOLETTA MARK G
19 Apr 2017
EVP & Chief Financial Officer
Buy
5,000
$10.00
$50.00K
Das Asha
19 Apr 2017
SVP & Chief Medical Officer
Buy
2,500
$10.00
$25.00K

What was left out

Form 4 filings counted 197
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 1,455,058
Sales filed before the plan box existed 3
History held since 12 Apr 2017